At a glance
ClinicalIndex Comparison RecordN/ACompleted· 334 enrolled
Drug / intervention
Trima Accel System with Version 7.0 Softwaredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Performance of Trima Accel® Version 7.0 Software Enhancements for the Collection of Platelets Stored in 100% Plasma
In Brief
A clinical study evaluating Trima Accel System with Version 7.0 Software for Healthy Volunteers. Completed, enrolled 334 participants across 7 sites.
Detailed Summary
To verify that platelets collected on the Trima Accel system with Version 7.0 software enhancements and stored in 100% plasma meet the FDA requirements for leukoreduction (\< 5.0 × 10\^6 residual white blood cells \[WBC\] per transfusable unit).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartApr 2016
First PostedApr 2016
Primary CompletionFeb 2017
TodayJul 2026
First PostedApr 28, 2016
Enrollment StartApr 1, 2016
Primary CompletionFeb 15, 2017
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 10.2 years ago
Interventions
Trima Accel System with Version 7.0 Softwaredevice
Platelet Apheresis Procedure